Quanex Building Products Announces Second Quarter 2023 Results and Reaffirms Full Year 2023 Guidance
Margin Expansion in NA Cabinet Components and EU Fenestration Segments
Repaid
Balance Sheet and Liquidity Remain Strong
Significant Improvement in Cash Provided by Operating Activities
Synergy Target Achieved for LMI Custom Mixing Acquisition
Return to Normal Seasonality Trending as Expected
Remain Cautiously Optimistic on Second Half of 2023
HOUSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2023.
The Company reported the following selected financial results:
QUANEX BUILDING PRODUCTS CORPORATION | |||||||||||||
Q2 2023 Earnings Release | |||||||||||||
Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||
($ in millions, except per share data) | 2023 | 2022 | 2023 | 2022 | |||||||||
Net Sales | |||||||||||||
Gross Margin | |||||||||||||
Gross Margin % | 24.6% | 22.7% | 22.2% | 21.8% | |||||||||
Net Income | |||||||||||||
Diluted EPS | |||||||||||||
Adjusted Net Income | |||||||||||||
Adjusted Diluted EPS | |||||||||||||
Adjusted EBITDA | |||||||||||||
Adjusted EBITDA Margin % | 14.6% | 14.0% | 11.3% | 11.8% | |||||||||
Cash Provided by (Used For) Operating Activities | ( | ||||||||||||
Free Cash Flow | ( |
(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)
George Wilson, President and Chief Executive Officer, commented, “We are pleased with the results we reported for the second quarter of 2023, and we are now more confident in our belief that we are seeing a return to normal seasonality in our business. Demand improved across all product lines during the second quarter of this year compared to the first quarter of this year, and we executed well from an operational standpoint. The customer inventory rebalancing initiatives that impacted results in our fenestration segments in the first quarter also impacted results in the second quarter, albeit to a lesser degree. However, based on ongoing conversations with our customers, coupled with recent order trends, we do not anticipate a meaningful impact from customer inventory rebalancing initiatives for the remainder of the year. The LMI Custom Mixing business we acquired on November 1, 2022 continues to perform well and we have already achieved our synergy target.
“When compared to the second quarter of 2022, which was a record quarter, revenue declined in the second quarter of 2023 across all operating segments as ongoing macroeconomic challenges spurred continued market volume declines and some pricing pressure, mostly due to surcharge rollbacks and index pricing mechanism triggers in North America as raw material costs decline. Despite the pressure on revenue, we converted well operationally and realized margin expansion in our North American Cabinet Components and European Fenestration segments. We controlled the things we can control, and we will continue to focus on operational efficiency and flexing our cost structure accordingly.
“Our continued focus on managing working capital is serving us well and we were able to generate enough free cash to buyback
Second Quarter 2023 Results Summary
The Company reported net sales of
The decrease in earnings for the three months ended April 30, 2023 was mostly attributable to lower volumes, decreased pricing mainly due to surcharge rollbacks and raw material index pricing mechanisms in North America, foreign exchange translation, and higher interest expense.
Balance Sheet Update
As of April 30, 2023, Quanex had total debt of
Outlook
Mr. Wilson stated, “We continue to be cautiously optimistic for the second half of our fiscal year, especially as we gain confidence from recent results and our belief that we are seeing a return to normal seasonality. In addition, the long-term underlying fundamentals for the residential housing market remain positive. Based on conversations with our customers and recent demand trends, we are reaffirming prior guidance for fiscal 2023. On a consolidated basis, we continue to estimate that we will generate net sales of
Our capital allocation priorities continue to be generating cash, paying down debt, evaluating growth opportunities and opportunistically buying back our stock.”
*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.
Conference Call and Webcast Information
The Company has also scheduled a conference call for Friday, June 2, 2023 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.
Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BI63b3d21eb76d4b8ba3f1693da2ce90ac
Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.
About Quanex
Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.
For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.
Non-GAAP Terminology Definitions and Disclaimers
Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement. Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance. Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.
Forward Looking Statements
Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2022, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.
QUANEX BUILDING PRODUCTS CORPORATION | |||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME | |||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||
Net sales | $ | 273,535 | $ | 322,893 | $ | 535,451 | $ | 589,933 | |||||||||
Cost of sales | 206,372 | 249,651 | 416,521 | 461,485 | |||||||||||||
Selling, general and administrative | 27,371 | 28,129 | 64,115 | 58,952 | |||||||||||||
Depreciation and amortization | 10,456 | 10,563 | 21,076 | 20,820 | |||||||||||||
Operating income | 29,336 | 34,550 | 33,739 | 48,676 | |||||||||||||
Interest expense | (2,244 | ) | (602 | ) | (4,503 | ) | (1,125 | ) | |||||||||
Other, net | (29 | ) | 453 | 189 | 507 | ||||||||||||
Income before income taxes | 27,063 | 34,401 | 29,425 | 48,058 | |||||||||||||
Income tax expense | (5,551 | ) | (7,879 | ) | (6,004 | ) | (10,297 | ) | |||||||||
Net income | $ | 21,512 | $ | 26,522 | $ | 23,421 | $ | 37,761 | |||||||||
Earnings per common share, basic | $ | 0.65 | $ | 0.80 | $ | 0.71 | $ | 1.14 | |||||||||
Earnings per common share, diluted | $ | 0.65 | $ | 0.80 | $ | 0.71 | $ | 1.13 | |||||||||
Weighted average common shares outstanding: | |||||||||||||||||
Basic | 32,858 | 33,157 | 32,905 | 33,140 | |||||||||||||
Diluted | 33,017 | 33,291 | 33,070 | 33,292 | |||||||||||||
Cash dividends per share | $ | 0.08 | $ | 0.08 | $ | 0.16 | $ | 0.16 | |||||||||
QUANEX BUILDING PRODUCTS CORPORATION | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(In thousands) | ||||||||
(Unaudited) | ||||||||
April 30, 2023 | October 31, 2022 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 43,496 | $ | 55,093 | ||||
Accounts receivable, net | 94,038 | 96,018 | ||||||
Inventories, net | 114,015 | 120,890 | ||||||
Prepaid and other current assets | 12,210 | 8,664 | ||||||
Total current assets | 263,759 | 280,665 | ||||||
Property, plant and equipment, net | 242,521 | 180,400 | ||||||
Operating lease right-of-use assets | 45,725 | 56,000 | ||||||
Goodwill | 185,224 | 137,855 | ||||||
Intangible assets, net | 80,981 | 65,035 | ||||||
Other assets | 3,902 | 4,662 | ||||||
Total assets | $ | 822,112 | $ | 724,617 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 64,477 | $ | 77,907 | ||||
Accrued liabilities | 44,655 | 52,114 | ||||||
Income taxes payable | - | 1,049 | ||||||
Current maturities of long-term debt | 2,113 | 1,046 | ||||||
Current operating lease liabilities | 7,403 | 7,727 | ||||||
Total current liabilities | 118,648 | 139,843 | ||||||
Long-term debt | 132,150 | 29,628 | ||||||
Noncurrent operating lease liabilities | 39,215 | 49,286 | ||||||
Deferred pension benefits | - | 3,917 | ||||||
Deferred income taxes | 23,396 | 22,277 | ||||||
Other liabilities | 15,976 | 14,831 | ||||||
Total liabilities | 329,385 | 259,782 | ||||||
Stockholders’ equity: | ||||||||
Common stock | 372 | 372 | ||||||
Additional paid-in-capital | 250,427 | 251,947 | ||||||
Retained earnings | 355,557 | 337,456 | ||||||
Accumulated other comprehensive loss | (34,968 | ) | (49,422 | ) | ||||
Treasury stock at cost | (78,661 | ) | (75,518 | ) | ||||
Total stockholders’ equity | 492,727 | 464,835 | ||||||
Total liabilities and stockholders' equity | $ | 822,112 | $ | 724,617 | ||||
QUANEX BUILDING PRODUCTS CORPORATION | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW | |||||||
(In thousands) | |||||||
(Unaudited) | |||||||
Six Months Ended April 30, | |||||||
2023 | 2022 | ||||||
Operating activities: | |||||||
Net income | $ | 23,421 | $ | 37,761 | |||
Adjustments to reconcile net income to cash provided by (used for) operating activities: | |||||||
Depreciation and amortization | 21,076 | 20,820 | |||||
Loss on the disposition of capital assets | |||||||
Stock-based compensation | 1,398 | 1,124 | |||||
Deferred income tax | 97 | 583 | |||||
Other, net | 982 | 1,534 | |||||
Changes in assets and liabilities: | |||||||
Decrease (increase) in accounts receivable | 11,564 | (13,008 | ) | ||||
Decrease (increase) in inventory | 14,799 | (39,771 | ) | ||||
Increase in other current assets | (1,746 | ) | (3,541 | ) | |||
(Decrease) increase in accounts payable | (19,825 | ) | 7,381 | ||||
Decrease in accrued liabilities | (14,407 | ) | (15,984 | ) | |||
(Decrease) increase in income taxes payable | (1,754 | ) | 1,679 | ||||
Increase (decrease) in deferred pension benefits | 17 | (159 | ) | ||||
Increase in other long-term liabilities | 1,808 | 443 | |||||
Other, net | 1,030 | (743 | ) | ||||
Cash provided by (used for) operating activities | 38,460 | (1,881 | ) | ||||
Investing activities: | |||||||
Business acquisition | (91,302 | ) | - | ||||
Capital expenditures | (15,074 | ) | (13,785 | ) | |||
Proceeds from disposition of capital assets | 101 | 36 | |||||
Cash used for investing activities | (106,275 | ) | (13,749 | ) | |||
Financing activities: | |||||||
Borrowings under credit facilities | 102,000 | 70,500 | |||||
Repayments of credit facility borrowings | (35,000 | ) | (45,500 | ) | |||
Repayments of other long-term debt | (1,306 | ) | (432 | ) | |||
Common stock dividends paid | (5,320 | ) | (5,258 | ) | |||
Issuance of common stock | 99 | 173 | |||||
Payroll tax paid to settle shares forfeited upon vesting of stock | (567 | ) | (1,412 | ) | |||
Purchase of treasury stock | (5,593 | ) | (1,569 | ) | |||
Cash used for financing activities | 54,313 | 16,502 | |||||
Cash provided by financing activities | 1,905 | (2,033 | ) | ||||
Decrease in cash and cash equivalents | (11,597 | ) | (1,161 | ) | |||
Cash and cash equivalents at beginning of period | 55,093 | 40,061 | |||||
Cash and cash equivalents at end of period | $ | 43,496 | $ | 38,900 | |||
QUANEX BUILDING PRODUCTS CORPORATION | ||||||||||
Reconciliations of Free Cash Flow and Net Debt | ||||||||||
(In thousands) | ||||||||||
(Unaudited) | ||||||||||
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | ||||||||||
Three Months Ended April 30, | Six Months Ended April 30, | |||||||||
2023 | 2022 | 2023 | 2022 | |||||||
Cash provided by (used for) operating activities | ( | |||||||||
Capital expenditures | (7,492) | (6,415) | (15,074) | (13,785) | ||||||
Free Cash Flow | ( | |||||||||
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | ||||||||||
As of April 30, | ||||||||||
2023 | 2022 | |||||||||
Revolving credit facility | ||||||||||
Finance lease obligations (1) | 55,626 | 13,971 | ||||||||
Total debt (2) | 135,626 | 76,971 | ||||||||
Less: Cash and cash equivalents | 43,496 | 38,900 | ||||||||
Net Debt | ||||||||||
(1) Includes | ||||||||||
(2) Excludes outstanding letters of credit. |
QUANEX BUILDING PRODUCTS CORPORATION | ||||||||||||||||||||
NON-GAAP FINANCIAL MEASURE DISCLOSURE | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
Reconciliation of Last Twelve Months Adjusted EBITDA | Three Months Ended April 30, 2023 | Three Months Ended January 31, 2023 | Three Months Ended October 31, 2022 | Three Months Ended July 31, 2022 | Total | |||||||||||||||
Reconciliation | Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||||
Net income as reported | $ | 21,512 | $ | 1,909 | $ | 24,667 | $ | 25,908 | $ | 73,996 | ||||||||||
Income tax expense | 5,551 | 453 | 3,329 | 7,801 | 17,134 | |||||||||||||||
Other, net | 29 | (218 | ) | (136 | ) | (398 | ) | (723 | ) | |||||||||||
Interest expense | 2,244 | 2,259 | 710 | 724 | 5,937 | |||||||||||||||
Depreciation and amortization | 10,456 | 10,620 | 9,555 | 9,734 | 40,365 | |||||||||||||||
EBITDA | 39,792 | 15,023 | 38,125 | 43,769 | 136,709 | |||||||||||||||
Cost of sales (1) | 48 | - | - | - | 48 | |||||||||||||||
Selling, general and administrative (1),(2) | 63 | 5,448 | 564 | 419 | 6,494 | |||||||||||||||
Adjusted EBITDA | $ | 39,903 | $ | 20,471 | $ | 38,689 | $ | 44,188 | $ | 143,251 | ||||||||||
(1) Loss on damage to manufacturing facilities caused by weather. | ||||||||||||||||||||
(2) Transaction and advisory fees. | ||||||||||||||||||||
QUANEX BUILDING PRODUCTS CORPORATION | |||||||||||||||||
NON-GAAP FINANCIAL MEASURE DISCLOSURE | |||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Three Months Ended | SIx Months Ended | SIx Months Ended | ||||||||||||||
Reconciliation of Adjusted Net Income and Adjusted EPS | April 30, 2023 | April 30, 2022 | April 30, 2023 | April 30, 2022 | |||||||||||||
Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | ||||||||||
Net income as reported | |||||||||||||||||
Net income reconciling items from below | 195 | 1 | $ - | 4,349 | 34 | ||||||||||||
Adjusted net income and adjusted EPS | |||||||||||||||||
Reconciliation of Adjusted EBITDA | Three Months Ended April 30, 2023 | Three Months Ended April 30, 2022 | Six Months Ended April 30, 2023 | Six Months Ended April 30, 2022 | |||||||||||||
Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||
Net income as reported | |||||||||||||||||
Income tax expense | 5,551 | 7,879 | 6,004 | 10,297 | |||||||||||||
Other, net | 29 | (453) | (189) | (507) | |||||||||||||
Interest expense | 2,244 | 602 | 4,503 | 1,125 | |||||||||||||
Depreciation and amortization | 10,456 | 10,563 | 21,076 | 20,820 | |||||||||||||
EBITDA | 39,792 | 45,113 | 54,815 | 69,496 | |||||||||||||
EBITDA reconciling items from below | 111 | 131 | 5,559 | 131 | |||||||||||||
Adjusted EBITDA | |||||||||||||||||
Reconciling Items | Three Months Ended April 30, 2023 | Three Months Ended April 30, 2022 | Six Months Ended April 30, 2023 | Six Months Ended April 30, 2022 | |||||||||||||
Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | ||||||||||
Net sales | $ - | $ - | $ - | $ - | |||||||||||||
Cost of sales | 206,372 | (48) | (1) | 249,651 | - | 416,521 | (48) | (1) | 461,485 | - | |||||||
Selling, general and administrative | 27,371 | (63) | (1),(2) | 28,129 | (131) | (2) | 64,115 | (5,511) | (1),(2) | 58,952 | (131) | (2) | |||||
EBITDA | 39,792 | 111 | 45,113 | 131 | 54,815 | 5,559 | 69,496 | 131 | |||||||||
Depreciation and amortization | 10,456 | - | 10,563 | - | 21,076 | - | 20,820 | - | |||||||||
Operating income | 29,336 | 111 | 34,550 | 131 | 33,739 | 5,559 | 48,676 | 131 | |||||||||
Interest expense | (2,244) | - | (602) | - | (4,503) | - | (1,125) | - | |||||||||
Other, net | (29) | 132 | (3) | 453 | (123) | (3) | 189 | 90 | (3) | 507 | (82) | (3) | |||||
Income before income taxes | 27,063 | 243 | 34,401 | 8 | 29,425 | 5,649 | 48,058 | 49 | |||||||||
Income tax expense | (5,551) | (48) | (4) | (7,879) | (7) | (4) | (6,004) | (1,300) | (4) | (10,297) | (15) | (4) | |||||
Net income | |||||||||||||||||
Diluted earnings per share | |||||||||||||||||
(1) Loss on damage to manufacturing facilities caused by weather. | |||||||||||||||||
(2) Transaction and advisory fees. | |||||||||||||||||
(3) Foreign currency transaction losses (gains). | |||||||||||||||||
(4) Tax impact of net income reconciling items. |
QUANEX BUILDING PRODUCTS CORPORATION | ||||||||||||||||||||
SELECTED SEGMENT DATA | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | ||||||||||||||||||||
NA Fenestration | EU Fenestration | NA Cabinet Components | Unallocated Corp & Other | Total | ||||||||||||||||
Three months ended April 30, 2023 | ||||||||||||||||||||
Net sales | $ | 156,975 | $ | 63,763 | $ | 53,518 | $ | (721 | ) | $ | 273,535 | |||||||||
Cost of sales | 122,472 | 40,452 | 43,731 | (283 | ) | 206,372 | ||||||||||||||
Gross Margin | 34,503 | 23,311 | 9,787 | (438 | ) | 67,163 | ||||||||||||||
Gross Margin % | 22.0% | 36.6% | 18.3% | 24.6% | ||||||||||||||||
Selling, general and administrative | 14,158 | 8,452 | 5,971 | (1,210 | ) | 27,371 | ||||||||||||||
Depreciation and amortization | 5,050 | 2,353 | 2,970 | 83 | 10,456 | |||||||||||||||
Operating income | 15,295 | 12,506 | 846 | 689 | 29,336 | |||||||||||||||
Depreciation and amortization | 5,050 | 2,353 | 2,970 | 83 | 10,456 | |||||||||||||||
EBITDA | 20,345 | 14,859 | 3,816 | 772 | 39,792 | |||||||||||||||
Loss on damage to manufacturing facilities (Cost of sales) | 35 | - | 13 | - | 48 | |||||||||||||||
Loss on damage to manufacturing facilities (SG&A) | - | - | 200 | - | 200 | |||||||||||||||
Transaction and advisory fees | - | - | - | (137 | ) | (137 | ) | |||||||||||||
Adjusted EBITDA | $ | 20,380 | $ | 14,859 | $ | 4,029 | $ | 635 | $ | 39,903 | ||||||||||
Adjusted EBITDA Margin % | 13.0% | 23.3% | 7.5% | 14.6% | ||||||||||||||||
Three months ended April 30, 2022 | ||||||||||||||||||||
Net sales | $ | 177,908 | $ | 73,427 | $ | 72,878 | $ | (1,320 | ) | $ | 322,893 | |||||||||
Cost of sales | 137,571 | 49,708 | 63,175 | (803 | ) | 249,651 | ||||||||||||||
Gross Margin | 40,337 | 23,719 | 9,703 | (517 | ) | 73,242 | ||||||||||||||
Gross Margin % | 22.7% | 32.3% | 13.3% | 22.7% | ||||||||||||||||
Selling, general and administrative | 14,078 | 8,601 | 5,218 | 232 | 28,129 | |||||||||||||||
Depreciation and amortization | 4,038 | 2,522 | 3,917 | 86 | 10,563 | |||||||||||||||
Operating income (loss) | 22,221 | 12,596 | 568 | (835 | ) | 34,550 | ||||||||||||||
Depreciation and amortization | 4,038 | 2,522 | 3,917 | 86 | 10,563 | |||||||||||||||
EBITDA | 26,259 | 15,118 | 4,485 | (749 | ) | 45,113 | ||||||||||||||
Transaction and advisory fees | - | - | - | 131 | 131 | |||||||||||||||
Adjusted EBITDA | $ | 26,259 | $ | 15,118 | $ | 4,485 | $ | (618 | ) | $ | 45,244 | |||||||||
Adjusted EBITDA Margin % | 14.8% | 20.6% | 6.2% | 14.0% | ||||||||||||||||
Six months ended April 30, 2023 | ||||||||||||||||||||
Net sales | $ | 309,955 | $ | 118,715 | $ | 108,192 | $ | (1,411 | ) | $ | 535,451 | |||||||||
Cost of sales | 247,189 | 78,155 | 91,787 | (610 | ) | 416,521 | ||||||||||||||
Gross Margin | 62,766 | 40,560 | 16,405 | (801 | ) | 118,930 | ||||||||||||||
Gross Margin % | 20.3% | 34.2% | 15.2% | 22.2% | ||||||||||||||||
Selling, general and administrative | 27,453 | 15,957 | 10,844 | 9,861 | 64,115 | |||||||||||||||
Depreciation and amortization | 10,295 | 4,701 | 5,904 | 176 | 21,076 | |||||||||||||||
Operating income (loss) | 25,018 | 19,902 | (343 | ) | (10,838 | ) | 33,739 | |||||||||||||
Depreciation and amortization | 10,295 | 4,701 | 5,904 | 176 | 21,076 | |||||||||||||||
EBITDA | 35,313 | 24,603 | 5,561 | (10,662 | ) | 54,815 | ||||||||||||||
Loss on damage to manufacturing facilities (Cost of sales) | 35 | - | 13 | - | 48 | |||||||||||||||
Loss on damage to manufacturing facilities (SG&A) | - | - | 200 | - | 200 | |||||||||||||||
Transaction and advisory fees | - | - | - | 5,311 | 5,311 | |||||||||||||||
Adjusted EBITDA | $ | 35,348 | $ | 24,603 | $ | 5,774 | $ | (5,351 | ) | $ | 60,374 | |||||||||
Adjusted EBITDA Margin % | 11.4% | 20.7% | 5.3% | 11.3% | ||||||||||||||||
Six months ended April 30, 2022 | ||||||||||||||||||||
Net sales | $ | 324,539 | $ | 132,341 | $ | 135,231 | $ | (2,178 | ) | $ | 589,933 | |||||||||
Cost of sales | 253,535 | 90,935 | 118,248 | (1,233 | ) | 461,485 | ||||||||||||||
Gross Margin | 71,004 | 41,406 | 16,983 | (945 | ) | 128,448 | ||||||||||||||
Gross Margin % | 21.9% | 31.3% | 12.6% | 21.8% | ||||||||||||||||
Selling, general and administrative | 28,455 | 15,904 | 10,488 | 4,105 | 58,952 | |||||||||||||||
Depreciation and amortization | 8,177 | 5,091 | 7,380 | 172 | 20,820 | |||||||||||||||
Operating income (loss) | 34,372 | 20,411 | (885 | ) | (5,222 | ) | 48,676 | |||||||||||||
Depreciation and amortization | 8,177 | 5,091 | 7,380 | 172 | 20,820 | |||||||||||||||
EBITDA | 42,549 | 25,502 | 6,495 | (5,050 | ) | 69,496 | ||||||||||||||
Transaction and advisory fees | - | - | - | 131 | 131 | |||||||||||||||
Adjusted EBITDA | $ | 42,549 | $ | 25,502 | $ | 6,495 | $ | (4,919 | ) | $ | 69,627 | |||||||||
Adjusted EBITDA Margin % | 13.1% | 19.3% | 4.8% | 11.8% | ||||||||||||||||
QUANEX BUILDING PRODUCTS CORPORATION | |||||||||||||||||
SALES ANALYSIS | |||||||||||||||||
(In thousands) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||
NA Fenestration:(1) | |||||||||||||||||
United States - fenestration | $ | 120,756 | $ | 156,843 | $ | 241,523 | $ | 285,210 | |||||||||
International - fenestration | 8,350 | 11,094 | 13,477 | 20,230 | |||||||||||||
United States - non-fenestration | 24,334 | 7,077 | 47,400 | 13,793 | |||||||||||||
International - non-fenestration | 3,535 | 2,894 | 7,555 | 5,306 | |||||||||||||
$ | 156,975 | $ | 177,908 | $ | 309,955 | $ | 324,539 | ||||||||||
EU Fenestration:(2) | |||||||||||||||||
International - fenestration | $ | 47,903 | $ | 54,863 | $ | 90,257 | $ | 99,484 | |||||||||
International - non-fenestration | 15,860 | 18,564 | 28,458 | 32,857 | |||||||||||||
$ | 63,763 | $ | 73,427 | $ | 118,715 | $ | 132,341 | ||||||||||
NA Cabinet Components: | |||||||||||||||||
United States - fenestration | $ | 4,219 | $ | 4,666 | $ | 8,127 | $ | 8,431 | |||||||||
United States - non-fenestration | 48,526 | 67,383 | 98,575 | 125,150 | |||||||||||||
International - non-fenestration | 773 | 829 | 1,490 | 1,650 | |||||||||||||
$ | 53,518 | $ | 72,878 | $ | 108,192 | $ | 135,231 | ||||||||||
Unallocated Corporate & Other: | |||||||||||||||||
Eliminations | $ | (721 | ) | $ | (1,320 | ) | $ | (1,411 | ) | $ | (2,178 | ) | |||||
$ | (721 | ) | $ | (1,320 | ) | $ | (1,411 | ) | $ | (2,178 | ) | ||||||
Net Sales | $ | 273,535 | $ | 322,893 | $ | 535,451 | $ | 589,933 | |||||||||
(1) Includes the net sales from the acquisition of LMI of | |||||||||||||||||
(2) Reflects a reduction of | |||||||||||||||||